| Advantages | Suitable for cancer biology research, biomarker discovery, and precision drug screening, these organoids provide a reliable platform for studying gallbladder cancer progression and evaluating therapeutic strategies. |
| Species | Human |
| Product Type | Tissue-derived Organoid |
| Growth Properties | Embedded 3D Culture |
| Growth Conditions | Cultured at 37°C under 95% air and 5% CO2. |
| Quality Control | Negative for mycoplasma, bacteria, yeast, and fungi. |
| Tissue | Gallbladder |
| Disease | Cancer |
| Format | Frozen |
| Organoid Characterization | They preserve key pathological features, including tumor heterogeneity, genetic mutations, and drug response profiles. |
| Applications | Tissue-derived organoids are broadly applied in drug screening, disease modeling, mechanistic studies, personalized medicine, and regenerative medicine. Through accurate recapitulation of disease states, they serve as an ideal platform for evaluating patient-specific responses to new therapeutics and guiding personalized treatment strategies. Moreover, these organoids enable the development of innovative therapeutic approaches, especially in oncology and tissue regeneration, delivering sophisticated experimental tools that significantly advance precision medicine. |
| Storage | Liquid Nitrogen |
| Shipping Information | Dry Ice |
For preclinical research and development use only; not intended for therapeutic or other applications.
Alfa Cytology is a preclinical research service provider specializing in tumor organoid development. We provide one-stop services that include tailored 3D cancer models, organoid-based research services, and related products to accelerate the discovery and development of cancer therapeutics.
Copyright © 2026 Alfa Cytology. All rights reserved.